You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

edp1815

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers Trial in Leiden (EDP1815, EDP2939, Placebo oral capsule)

Recruiting
  • KLH and Imiquimod Induced Skin Inflammation in Healthy Volunteers
  • EDP1815
  • +2 more
  • Leiden, Netherlands
    Centre for Human Drug Research
Jan 11, 2023

Covid19 Trial in New Brunswick, Newark (EDP1815, Placebo)

Terminated
  • Covid19
  • EDP1815
  • Placebo
  • New Brunswick, New Jersey
  • +1 more
Oct 29, 2021

Psoriasis, Atopic Dermatitis Trial in United Kingdom (EDP1815, Placebo oral capsule, Placebo oral tablet)

Completed
  • Psoriasis
  • Atopic Dermatitis
  • EDP1815
  • +2 more
  • Barnsley, United Kingdom
  • +8 more
Jan 6, 2022

Atopic Dermatitis Trial in Worldwide (EDP1815, Placebo)

Active, not recruiting
  • Atopic Dermatitis
  • EDP1815
  • Placebo
  • Birmingham, Alabama
  • +58 more
Nov 3, 2022

Atopic Dermatitis Trial in Worldwide (EDP1815)

Enrolling by invitation
  • Atopic Dermatitis
  • EDP1815
  • Fountain Valley, California
  • +57 more
Jun 27, 2022

Psoriasis, Plaque Psoriasis Trial in Worldwide (EDP1815, Placebo)

Completed
  • Psoriasis
  • Plaque Psoriasis
  • EDP1815
  • Placebo
  • Santa Rosa, California
  • +28 more
Jan 6, 2022

COVID-19 Trial in Cambridge (EDP1815, Dapagliflozin, Ambrisentan)

Recruiting
  • COVID-19
  • EDP1815
  • +3 more
  • Cambridge, Cambridgeshire, United Kingdom
    Cambridge University Hospitals NHS Foundation Trust
Jun 9, 2021